Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice

被引:85
作者
Turmel, H
Hartmann, A
Parain, K
Douhou, A
Srinivasan, A
Agid, Y
Hirsch, EC
机构
[1] Hop La Pitie Salpetriere, INSERM, U289, F-75013 Paris, France
[2] IDUN Pharmaceut Inc, La Jolla, CA USA
关键词
Parkinson's disease; MPTP; MPP+; apoptosis; caspase-3;
D O I
10.1002/mds.1037
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In 1-methyl-4-phenyl-1,2,3.6-tetrahydropyridine (MPTP) models of Parkinson's disease (PD), dopaminergic (DA) neurons have been shown to die by apoptosis. Moreover, recent postmortem and in vitro results have indicated that apoptotic cell death induced by 1-methyl-4-phenylpyridinium (MPP+) may be mediated by caspase-3. To establish whether caspase-3 activation may indeed play a role in an in vivo model of PD, we studied caspase-3 activation in C57B1/6 mice: sub chronically intoxicated with MPTP. We show that caspase-3 activation peaks early, at days 1 and 2 after the end of MPTP intoxication. In contrast, pycnotic neurons persist until day 7 postintoxication, indicating that caspase-3 activation is an early and transient phenomenon in apoptotic death of DA neurons. We further demonstrate that loss of tyrosine hydroxylase (TH) immunoreactivity in this model is indeed due to cell loss rather than to loss of TH protein expression, We conclude that mice subchronically intoxicated with MPTP represent a valid PD model to study and manipulate caspase activation in vivo. (C) 2001 Movement Disorder Society.
引用
收藏
页码:185 / 189
页数:5
相关论文
共 20 条
[1]  
Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.3.CO
[2]  
2-5
[3]   Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration [J].
Cutillas, B ;
Espejo, M ;
Gil, J ;
Ferrer, I ;
Ambrosio, S .
NEUROREPORT, 1999, 10 (12) :2605-2608
[4]   Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons [J].
Dodel, RC ;
Du, Y ;
Bales, KR ;
Ling, ZD ;
Carvey, PM ;
Paul, SM .
NEUROSCIENCE, 1998, 86 (03) :701-707
[5]  
Du YS, 1997, J NEUROCHEM, V69, P1382
[6]   Mammalian caspases: Structure, activation, substrates, and functions during apoptosis [J].
Earnshaw, WC ;
Martins, LM ;
Kaufmann, SH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :383-424
[7]   Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease [J].
Hartmann, A ;
Hunot, S ;
Michel, PP ;
Muriel, MP ;
Vyas, S ;
Faucheux, BA ;
Mouatt-Prigent, A ;
Turmel, H ;
Srinivasan, A ;
Ruberg, M ;
Evan, GI ;
Agid, Y ;
Hirsch, EC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2875-2880
[8]   MELANIZED DOPAMINERGIC-NEURONS ARE DIFFERENTIALLY SUSCEPTIBLE TO DEGENERATION IN PARKINSONS-DISEASE [J].
HIRSCH, E ;
GRAYBIEL, AM ;
AGID, YA .
NATURE, 1988, 334 (6180) :345-348
[9]  
Hirsch EC, 1999, MOVEMENT DISORD, V14, P383, DOI 10.1002/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO
[10]  
2-F